Form 4: Sarepta Therapeutics CFO Ian Estepan Sells Shares to Cover Tax Obligations

Ian Michael Estepan, CFO of Sarepta Therapeutics, sold 5,985 shares of common stock on August 30, 2024, at a price of $137.36 per share to cover tax obligations related to vesting restricted stock units.

Summary

• On August 30, 2024, Ian Michael Estepan, the Chief Financial Officer of Sarepta Therapeutics, sold 5,985 shares of the company's common stock.
• The sale was executed at a price of $137.36 per share.
• The purpose of the sale was to generate cash to cover tax obligations arising from the vesting of restricted stock unit awards and other compensation.
• Following the transaction, Estepan directly owns 33,946 shares of Sarepta Therapeutics.

Sentiment

Score: 5

Explanation: The document reflects a routine transaction (stock sale for tax purposes) and doesn't indicate any significant positive or negative sentiment regarding the company's performance or future prospects.

Industry Context

Sales of shares by company executives to cover tax obligations are a common occurrence, especially after the vesting of stock options or restricted stock units. This is a normal part of executive compensation and financial planning.

Stakeholder Impact

• The sale of shares by a company executive could have a minor impact on shareholder sentiment, but is unlikely to have a significant impact on the company's operations or financial performance.

Key Dates